JANE STREET GROUP, LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 53 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2022$8,123
-75.4%
25,126
-2.1%
0.00%
Q4 2021$33,000
-50.7%
25,658
-39.3%
0.00%
Q2 2021$67,000
-36.8%
42,251
-1.9%
0.00%
Q3 2020$106,000
-64.2%
43,052
-48.3%
0.00%
Q2 2020$296,000
+557.8%
83,321
+337.1%
0.00%
Q1 2020$45,000
+2.3%
19,063
+40.2%
0.00%
Q3 2016$44,00013,6000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2021
NameSharesValueWeighting ↓
MARATHON CAPITAL MANAGEMENT 55,000$179,0000.09%
WEDBUSH SECURITIES INC 180,945$590,0000.09%
Brown Advisory Securities, LLC 28,000$91,0000.03%
FNY Managed Accounts LLC 8,000$26,080,0000.02%
FT Options LLC 10,000$26,0000.02%
WEBSTER BANK, N. A. 40,000$130,0000.02%
GSA CAPITAL PARTNERS LLP 30,907$101,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$82,0000.00%
NATIONAL PLANNING CORP 11,000$32,0000.00%
Virtu KCG Holdings LLC 24,705$81,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders